Skip to main content
. 2020 Jan 13;91(2):139–145. doi: 10.1080/17453674.2019.1710804

Table 3.

Results and complications before and after introduction of the Hip Fracture Unit

Variable HFU group n = 276 Control group n = 167 Relative risk and/or (CI)
Waiting time before surgery, mean h 24 29 (1.6–7.6)
Operated within 48 hours, n (%) 260/271 (96) 139/163 (85) 1.1 (1.0–1.2)
Operated within 24 hours, n (%) 157/271 (58) 83/163 (51) 1.1 (0.9–1.4)
Started anti-osteoporosis drug      
treatment during stay, n (%) 123/273 (47) 1 (0.5)  
 Zoledronic acid 95 1  
 Alendronate 3 0  
 Denosumab 25 0  
Days of hospital stay, median (range) 5 (2–30) 8 (1–39) (2.2–3.7)
Postoperative surgical complications, n (%) 22 (8) 8 (5) 1.6 (0.7–3.6)
 Deep wound infection 9 1  
 Prosthetic dislocation 2 3  
 Fixation failure 6 3  
 Other a 5 1  
Readmitted in 30 days, n (%) 32/271 (12) 13/165 (8) 1.5 (0.8–2.7)
Reoperated at 4 months, n (%) 16/276 (6) 5/164 (3) 1.9 (0.7–5.1)
 at 12 months (accumulated), n (%) 18/276 (7) 9/164 (6) 1.2 (0.5–2.5)
New admissions to a permanent care      
facility at 4 months, n (%)b 41/172 (24) 18/83 (22) 1.1 (0.6–1.7)
Dead at 4 months 43 (15) 25 (15) 1.0 (0.6–1.6)
Dead at 12 months 63 (23) 43 (26) 0.9 (0.9–1.1)
a

Other surgical complications were: 1 trochanteric avulsion. 1 peroneal nerve palsy. 1 reoperated for hematoma. 1 hemiarthroplasty had soft tissue interposed in the acetabulum. 1 reoperated for gluteus medius insufficiency. 1 had a skin laceration of the leg after a fall in the ward.

b

Patients who lived in a permanent care facility preoperatively were excluded.